Difference between revisions of "Marechal R, et al. Br. J. Cancer (2009) cited as Ref 738 in DOI: 10.1038/s41392-020-0110-5 (Q10001)"
Jump to navigation
Jump to search
(Created claim: title (P93): High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Page(s) (P105): 1444-1451, #quickstatements; #temporary_batch_1590074839150) |
||
| Property / Page(s) | |||
| + | 1444-1451 | ||
| Property / Page(s): 1444-1451 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:51, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Marechal R, et al. Br. J. Cancer (2009) cited as Ref 738 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Marechal R
0 references
2009
0 references
Br. J. Cancer
0 references
100
0 references
High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma (English)
0 references
1444-1451
0 references
